Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Erlotinib and Radiation Therapy in Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01192815
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:42.757020+00:00
Published At
2020-05-12T00:00:00+00:00
Record Updated At
2020-05-12
Results Posted At
2020-05-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Stage III Squamous Cell Carcinoma of the Hypopharynx", "Stage III Squamous Cell Carcinoma of the Larynx", "Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity", "Stage III Squamous Cell Carcinoma of the Oropharynx", "Stage III Verrucous Carcinoma of the Larynx", "Stage III Verrucous Carcinoma of the Oral Cavity", "Stage IV Squamous Cell Carcinoma of the Hypopharynx", "Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity", "Stage IV Squamous Cell Carcinoma of the Nasopharynx", "Stage IV Squamous Cell Carcinoma of the Oropharynx", "Stage IV Verrucous Carcinoma of the Larynx", "Stage IV Verrucous Carcinoma of the Oral Cavity"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-05-12"
protocolSection.identificationModule.nctId
"NCT01192815"
protocolSection.identificationModule.officialTitle
"A Phase II Study of Erlotinib and Radiation Therapy in Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-05-12"

Study condition terms

  • Stage III Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
  • Stage III Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage III Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Stage III Verrucous Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Stage III Verrucous Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Nasopharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Verrucous Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Stage IV Verrucous Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.